INDUSTRY: Cannabis / Alternative Wellness / Plant-Based CPG
PROBLEM STATEMENT: As cannabis and plant-based wellness markets mature, investors face fragmented regulations, uneven asset quality, and high operational risk when backing single operators. There are limited ways to gain diversified, professionally managed exposure to cash-flowing brands and limited-license markets while still participating in long-term upside as regulations and consumer demand expand.
SOLUTION: Sun Theory is a leading holding group in plant-based wellness and cannabis, launching SPV IV as an asset-backed portfolio of five brands and dispensaries (including an Arnold Palmer licensing deal). Building on three prior vehicles with a weighted average ROIC of 21%, SPV IV targets 58.8% net IRR and ~$35M LTM revenue (with ~$100M expected in 2025). The strategy focuses on exclusive licenses, defensible distribution, and established, cash-flowing brands, with multiple portfolio companies already EBITDA positive. Sun Theory is vertically integrated and owns key dispensaries, providing control over distribution and positioning the fund to benefit from supply constraints, regulatory clarity, and the shift toward alternative wellness. SPV IV is a $60M vehicle with $45M already committed and an exclusive $5M allocation for Happy Wellness Group (minimum $250K check).
DELIVERABLES:
Pitch Deck, Data Room
